193 related articles for article (PubMed ID: 10355821)
1. Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides.
Brown-Driver V; Eto T; Lesnik E; Anderson KP; Hanecak RC
Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):145-54. PubMed ID: 10355821
[TBL] [Abstract][Full Text] [Related]
2. Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation.
Alt M; Renz R; Hofschneider PH; Caselmann WH
Arch Virol; 1997; 142(3):589-99. PubMed ID: 9349305
[TBL] [Abstract][Full Text] [Related]
3. Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides.
Alt M; Renz R; Hofschneider PH; Paumgartner G; Caselmann WH
Hepatology; 1995 Sep; 22(3):707-17. PubMed ID: 7657273
[TBL] [Abstract][Full Text] [Related]
4. Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes.
Hanecak R; Brown-Driver V; Fox MC; Azad RF; Furusako S; Nozaki C; Ford C; Sasmor H; Anderson KP
J Virol; 1996 Aug; 70(8):5203-12. PubMed ID: 8764029
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C IRES: translating translation into a therapeutic target.
Jubin R
Curr Opin Mol Ther; 2001 Jun; 3(3):278-87. PubMed ID: 11497352
[TBL] [Abstract][Full Text] [Related]
6. Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation.
Alt M; Eisenhardt S; Serwe M; Renz R; Engels JW; Caselmann WH
Eur J Clin Invest; 1999 Oct; 29(10):868-76. PubMed ID: 10583429
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence.
Wakita T; Wands JR
J Biol Chem; 1994 May; 269(19):14205-10. PubMed ID: 8188703
[TBL] [Abstract][Full Text] [Related]
8. Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay.
Seki M; Honda Y
J Biochem; 1995 Dec; 118(6):1199-204. PubMed ID: 8720135
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of hepatitis C virus gene expression by chemically modified antisense oligodeoxynucleotides.
Vidalin O; Major ME; Rayner B; Imbach JL; Trépo C; Inchauspé G
Antimicrob Agents Chemother; 1996 Oct; 40(10):2337-44. PubMed ID: 8891141
[TBL] [Abstract][Full Text] [Related]
10. Translation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotides.
Hasselblatt P; Hockenjos B; Thoma C; Blum HE; Offensperger WB
Nucleic Acids Res; 2005; 33(1):114-25. PubMed ID: 15640448
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligonucleotides targeted to the domain IIId of the hepatitis C virus IRES compete with 40S ribosomal subunit binding and prevent in vitro translation.
Tallet-Lopez B; Aldaz-Carroll L; Chabas S; Dausse E; Staedel C; Toulmé JJ
Nucleic Acids Res; 2003 Jan; 31(2):734-42. PubMed ID: 12527783
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of hepatitis C virus RNA translation by antisense bile acid conjugated phosphorothioate modified oligodeoxynucleotides (ODN).
González-Carmona MA; Quasdorff M; Vogt A; Tamke A; Yildiz Y; Hoffmann P; Lehmann T; Bartenschlager R; Engels JW; Kullak-Ublick GA; Sauerbruch T; Caselmann WH
Antiviral Res; 2013 Jan; 97(1):49-59. PubMed ID: 23142319
[TBL] [Abstract][Full Text] [Related]
13. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides.
Moulds C; Lewis JG; Froehler BC; Grant D; Huang T; Milligan JF; Matteucci MD; Wagner RW
Biochemistry; 1995 Apr; 34(15):5044-53. PubMed ID: 7536034
[TBL] [Abstract][Full Text] [Related]
14. Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression.
Wakita T; Moradpour D; Tokushihge K; Wands JR
J Med Virol; 1999 Mar; 57(3):217-22. PubMed ID: 10022790
[TBL] [Abstract][Full Text] [Related]
15. Phosphorothioate-phosphodiester oligonucleotide co-polymers: assessment for antisense application.
Ghosh MK; Ghosh K; Cohen JS
Anticancer Drug Des; 1993 Feb; 8(1):15-32. PubMed ID: 8386513
[TBL] [Abstract][Full Text] [Related]
16. Short peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.
Alotte C; Martin A; Caldarelli SA; Di Giorgio A; Condom R; Zoulim F; Durantel D; Hantz O
Antiviral Res; 2008 Dec; 80(3):280-7. PubMed ID: 18625270
[TBL] [Abstract][Full Text] [Related]
17. 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.
Prakash TP; Johnston JF; Graham MJ; Condon TP; Manoharan M
Nucleic Acids Res; 2004; 32(2):828-33. PubMed ID: 14762210
[TBL] [Abstract][Full Text] [Related]
18. A human liver cell line exhibits efficient translation of HCV RNAs produced by a recombinant adenovirus expressing T7 RNA polymerase.
Aoki Y; Aizaki H; Shimoike T; Tani H; Ishii K; Saito I; Matsuura Y; Miyamura T
Virology; 1998 Oct; 250(1):140-50. PubMed ID: 9770428
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial screening and rational optimization for hybridization to folded hepatitis C virus RNA of oligonucleotides with biological antisense activity.
Lima WF; Brown-Driver V; Fox M; Hanecak R; Bruice TW
J Biol Chem; 1997 Jan; 272(1):626-38. PubMed ID: 8995306
[TBL] [Abstract][Full Text] [Related]
20. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation.
Wang H; Shen XT; Ye R; Lan SY; Xiang L; Yuan ZH
Arch Virol; 2005 Jun; 150(6):1085-99. PubMed ID: 15747050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
